Equity Overview
Price & Market Data
Price: $302.9
Daily Change: +$12.34 / 4.07%
Range: $287.0 - $303.8
Market Cap: $8,705,256,448
Volume: 572,668
Performance Metrics
1 Week: 2.15%
1 Month: -6.67%
3 Months: -12.94%
6 Months: -14.18%
1 Year: -19.50%
YTD: -8.83%
Company Details
Employees: 5900
Sector: Commercial services
Industry: Miscellaneous commercial services
Country: United States
Details
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.